Abstract
Introduction
Cardiovascular disease is a major cause of death or disability in many developed countries. Smoking, high cholesterol and obesity are well known risk factors of cardiovascular disease, and they are associated with decreased availability of endothelial cells-derived NO in the cardiovascular system. Isoflavones are phytoestrogens that have been gathering an increased interest in the areas of clinical nutrition and diseases prevention [1, 2] especially for post-menopausal women in view of the some unfavorable consequences/potential risks (e.g. stroke and coronary heart disease) associated with the use of estrogen-like substances (so-called hormone replacement therapy) [3] . Thus, there is an urgent need for estrogen alternatives (e.g. phytoestrogens) for providing beneficial cardiovascular effects. Recent studies provided evidence that isoflavones can restore endothelial dysfunction via an increase of NO generation [4] [5] [6] [7] [8] .
Formononetin (7-hydroxy-3(4-methoxypheny)chromone (C 16 H 12 O 4 ) (Fig. 1) ) is a isoflavonoid found abundantly in Traditional Chinese Medicine Astragalus mongholicus Bunge (known as Huang Qi in China and Ougi in Japan) and Trifolium pratense L (red clover) which belongs to the family Leguminosae. The extract of these herbs has been used clinically to treat different diseases including cardiovascular diseases in China for a long time [9] [10] [11] . In addition, formononetin possesses hypolipidemic properties [12] , mammary gland proliferation function [13] , anti-oxidative and estrogenic effects [14] . The extract of Astragalus membraneaceus 5 has also been demonstrated to possess endothelium-dependent and -independent vasodilatory effects [15] [16] [17] and daidzein, a metabolite of formononetin formed in vivo, can relax rats' aorta and pulmonary artery [18] [19] [20] . However, the underlying mechanisms of formononetin involved (especially its effects on ion channels modulation) in eliciting vasorelaxation has not been elucidated in details. Thus, in this study, we tested the hypothesis that formononetin-induced vascular relaxation involved the openings of K + channels of the vascular smooth muscle. More importantly, as formononetin is a phytoestrogen which shares a chemical structure similar to estrogen/progesterone ( Fig. 1 ), the participation of estrogen and progesterone receptors in mediating the vascular responses will be elucidated. 6 
Materials and methods

Drugs and chemicals
Formononetin was purchased from Acros Organics (Belgium) and the stock solution (100 mM) of formononetin was prepared in dimethyl sulphoxide and stored at -20 °C until use. Genistein, daidzein, biochanin A, phenylephrine hydrochloride, acetylcholine hydrochloride (ACh), neostigmine hydrobromide, indomethacin, 
Arterial rings preparation
Male Sprague-Dawley rats (~250-300 g) were killed by cervical dislocation, and thoracic aortas were dissected from animals immediately. The thoracic aortas were cleared from connective tissues and cut into rings (3 mm in length) and immersed in relaxation was considered when the phenylephrine-induced active tone returned to basal level. 8 The integrity of the functional endothelium was confirmed by acetylcholine (10 µM)-induced relaxation (> 85%) on high K + (30 mM) pre-constricted aortic preparations. In some studies, the successful removal of endothelium (by mechanical rubbing the lumen of the aorta with a blunted forceps) was considered when the acetylcholine (10 µM)-induced relaxation was < 5%. In studies with manoeuvres such as endothelium denudation and administration of L-NAME, concentration of phenylephrine added was adjusted (0.35 -0.6 µM) so as to achieve a comparable adhered to. Every effort was made to limit animal suffering and to limit the number of animals used in these experiments.
Incubation of aortic rings
To evaluate the in vitro effect of formononetin on isolated aorta, the aortas (thoracic and abdominal) were excised and cleared of all adherent tissues in ice-cold 9 phosphate buffered saline (pH 7.4) under sterile conditions. The isolated aortas were placed in ice-cold Krebs' solution, washed three times in phosphate buffered saline, and cut into segments of 1 cm long using a scalpel. Four aortic rings were obtained from each rat. The aortic rings were incubated in 24-well plate with physiological salt solution (2 ml per well) in the presence of 1 µM acetylcholine (plus 1 µM neostigmine, an anti-cholinesterase), formononetin (10 µM, 100 µM and 1 mM) or saline (served as control) under an atmosphere of 5% CO 2 and 95% O 2 at 37 °C. After 2 hr incubation, each segment was blotted dry and weighed, and immediately stored at -80 °C for NOS activity assay or in liquid nitrogen for RNA and protein extraction.
NO content in culture medium and NOS activity of aortic rings
After 2 hr incubation, the medium (2 ml) of each well was collected in micro-centrifuge tubes, and dried by vacuum freeze-drying. The pellets collected were re-dissolved in distilled water (300 µl). Nitric oxide content present in the medium was determined according to the Griess methods [21] , and nitrite concentrations were determined at 550 nm using the standard solutions of sodium nitrite.
The NOS activity of isolated aorta was measured as described previously [22] .
The frozen sample of aorta (weight = 0.03 -0.04 g) was homogenized in ice-cold saline (final concentration 10% (w/v)) and centrifuged (3000 rpm, 10 min). The supernatant collected was used for the determinations of total NOS (tNOS) and inducible NOS (iNOS) activities using kits following the instructions of manufactory. 10 The protein content was evaluated according to Bradford methods. Endothelial NOS (eNOS) activity was estimated (to measure the color change of reagent at 530 nm) as the difference between tNOS and iNOS. It is based on the fact that eNOS is a Ca 2+ -dependent isoform whereas iNOS is a Ca 2+ -independent isoform. Thus, the activity of iNOS was estimated in the presence of eNOS inhibitor (L-NAME) plus EGTA (2 mM, a Ca 2+ chelator) [22] . The NOS activities measured were expressed in U/mg protein.
Isolation and Quantification of mRNA
To determine the gene expression levels, total RNA was isolated from aorta using The second derivative maximum (log linear phase) for each amplification curve was determined using the GAPDH standard curve to calculate the amount of product generated. Each real-time RT-PCR reaction was performed in triplicate. The expression levels of mRNA were expressed as the ratios of mRNA expression of NOS enzyme to that of GAPDH.
Western immunoblot analysis of phospho-eNOS and eNOS protein expression on thoracic aortas
To determine the protein expression levels, thoracic aortas from different treatment groups were homogenized in the presence of protease inhibitors to obtain extracts of proteins. Protein concentrations were determined using BCA protein assay kit (Pierce, USA). Samples (25 µg of protein per lane) were loaded onto a 10% SDS-polyacrylamide electrophoresis gel. After electrophoresis (180V, 60 min), the separated proteins were transferred (12 mA, 45 min) to polyvinylidene difluoride membrane (PerkinElmer Life Sciences, USA). Non-specific sites were blocked with 5% non-fat dry milk for 120 min, and the blots were then incubated with anti- 
Isolation of aortic smooth muscle cells and patch-clamp electrophysiology
Rat aorta (endothelium denuded) smooth muscle cells were enzymatically dissociated (using collagenase and papain) with methods as reported previously by our group [23] [24] [25] for single cell patch-clamp electrophysiology experiments.
Solutions (external bathing solutions and pipette solutions) and voltage protocols used for whole-cell recordings of BK Ca and K ATP channels were similar to our previous reports [24, 25] .
Statistical analysis
Data are expressed as means ± S.E.M., and n denotes the number of replications for each data point. Relaxation was expressed as the percentage of the contraction elicited by phenylephrine. GraphPad Prism 4.02 (San Diego, California, USA) was used to fit sigmoidal curves and to determine the maximum relaxation effect. After validation of each parameter for homogeneity of variance, differences between groups
were assessed by one-way analysis of variance (ANOVA) using SPSS (Version 15)
software package for Windows (Chicago, IL, USA). Post hoc testing was performed
Results
Relaxation of rat aorta by formononetin
After the phenylephrine (1 µM)-induced contraction reached a sustained/steady-state condition, cumulative application of formononetin (0.1 -100 µM) caused a concentration-dependent relaxation and a maximum relaxation of 98.50 ± 1.50 % was observed in endothelium-intact preparation. Other phytoestrogens (genistein, daidzein and biochanin A) were evaluated and compared. Similar to formononetin, cumulative administration of these compounds caused a concentration-dependant relaxation of phenylephrine-preconstricted aorta (n = 5 -6) (Fig. 2) . Genistein (≤ 10 µM) elicited a smaller magnitude of relaxation compared to formononetin whereas biochanin A (> 1 µM) induced a similar degree of relaxation as produced by formononetin (Fig. 2) . In contrast, daidzein was the least potent one in causing aortic relaxation (Fig. 2 ). L-NAME (100 µM, a common eNOS inhibitor) and methylene blue (10 µM, an inhibitor of guanylate cyclase), but not 1400W (1 μM, a selective iNOS inhibitor) or propranolol (1 μM, a non-selective β-adrenoceptor blocker), markedly suppressed formononetin-induced relaxation in endothelium-intact preparations (Fig. 3A) .
In endothelium-denuded preparations, formononetin (over the same concentration range) elicited a lesser degree of relaxation and a maximum relaxation of 53.28 ± 3.70 % was observed (n = 5 -6) ( 
Role of K + channels activation in formononetin-induced relaxation of endothelium-denuded preparations
In endothelium-denuded preparations, glibenclamide (3 µM, an ATP-sensitive K + (K ATP ) channel blocker) markedly suppressed formononetin-mediated relaxation (n = 5) (Fig. 4A) . A higher concentration of glibenclamide (10 µM) was examined but the phenylephrine-induced active tone was not sustained (n = 6) (data not shown). Thus, effects of glibenclamide (10 µM) on formononetin-elicited relaxation could not be determined accurately. Similar to glibenclamide, iberiotoxin (100 nM, a potent and highly selective Ca 2+ -activated K + (BK Ca ) channel blocker) markedly reduced the magnitude of formononetin-induced relaxation in endothelium-denuded preparations (n = 5) (Fig. 4B) . A combination of glibenclamide (3 µM) plus iberiotoxin (100 nM) completely abolished formononetin-induced relaxation in endothelium-denuded preparations (n = 5) (Fig. 4C) . Application of glibenclamide, iberiotoxin and a combination of glibenclamide plus iberiotoxin did not alter the resting tension of the preparations (n = 5 -6) (data not shown).
In single aortic smooth muscle cells, formononetin (10 µM and 100 µM)
activated, in a concentration-dependent manner, the basal K ATP channel openings (n = 6) (Fig. 5A ) which was eradicated by glibenclamide (3 µM) (n = 6) (Fig. 5A ). In addition, formononetin (10 µM, 100 µM and 1 mM) activated, in a concentration-dependent manner, the basal BK Ca channels (n = 6) ( Fig. 5B ) which was sensitive to iberiotoxin (100 nM) (n = 6) (Fig. 5B) .
Determination of nitric oxide production
To further investigate the effects of formononetin on NO release from aortic endothelial cells, isolated aortic rings were treated with different concentrations of formononetin, and acetylcholine (1 µM) was used as the reference for comparison.
Before the addition of acetylcholine, no detectable levels of NO could be measured even after 2-hr incubation. Immediately after acetylcholine (1 µM) (with neostigmine (10 µM, an inhibitor of cholinesterase [26] )) was added, NO production was increased 17 and it reached 88.8 ± 6.44 µM NO per g of aortic ring (Control in Fig. 6 ) at the end of the incubation period. Similar to acetylcholine, formononetin (10 µM, 100 µM and 1 mM) caused a significant and concentration-dependant increase in NO release. The increase in NO production caused by formononetin (10 µM, 100 µM and 1 mM) were higher than that by acetylcholine (1 µM) by 2.5 % (P > 0.05), 14.5 % (P < 0.05) and 17.2 % (P < 0.001), respectively (n = 4) (Fig. 6) .
Determination of NOS activity
Formononetin (10 µM, 100 µM and 1 mM) markedly increased NOS (presumably eNOS) activity by 31.5% (3.56 ± 0.41 U/mg protein, P > 0.05), 65.6% (4.49 ± 0.34 U/mg protein, P < 0.05) and 70.8% (4.63 ± 1.28 U/mg protein, P < 0.05), respectively (n = 5) (Fig. 7) . In the absence of [Ca 2+ ] o (presumably representing iNOS activity), formononetin has no measurable effects on NOS activity (n = 5) (Fig. 7) .
Determination of eNOS mRNA and protein expression
Formononetin (10 µM, 100 µM and 1 mM) up-regulated eNOS mRNA expression, and a significant increase of eNOS mRNA expression of 1.26 ± 0.17 (92.5 %) and 1.60 ± 0.27 (142.9 %) was observed in the presence of 100 µM and 1 mM formononetin, respectively (n = 5) (Fig. 8A ). In addition, formononetin (10 µM, 100 µM and 1 mM) caused a concentration-dependent enhancement of 18 phospho-eNOS Ser1177 protein expression with no apparent change in total eNOS expression (n = 5) (Fig. 8B) . 19 
Discussion
The present study demonstrates, for the first time, that formononetin (a phytoestrogen) elicited a concentration-dependent relaxation of rat pre-contracted thoracic aortic rings through both endothelium-dependent and -independent mechanisms. Our results (using pharmacological/chemical and molecular biology approaches) illustrate that the endothelium-dependent component of formononetin-induced relaxation, similar to other NO/endothelium-related vasorelaxants, is associated with an increase in NO release which is due to an enhanced eNOS mRNA expression, protein expression of p-eNOS
Ser1177
(phosphorylated/activated form of eNOS) as well as an increase of eNOS activity.
However, our results revealed that acetylcholine managed to cause "a comparable magnitude" of NO release at a much lower concentration (i.e. 1 µM). These results therefore suggest that despite the fact that formononetin caused NO generation from endothelial cells of rat aorta, it is less potent than acetylcholine.
Other phytoestrogens tested in this study (genistein, daidzein and biochanin A) which shared a similar chemical structure to formononetin also elicited a concentration-dependent relaxation of endothelium-intact aorta with a "similar" relaxation profile. It is important to point out that daidzein (a metabolite of formononetin formed in vivo) was ~10-fold less potent than formononetin in producing relaxation. The discrepancy in relaxation responses of formononetin and daidzein observed in this study is unknown. It is tempting to speculate that 20 consumption of herbs e.g. red clove and Astragalus mongholicus Bunge which contain a high content of formononetin [27, 28] may provide greater beneficial effects (e.g. vasorelaxation) to the cardiovascular systems.
The presence of L-NAME (a common eNOS inhibitor) and methylene blue (a guanylate cyclase inhibitor) mimicked the effects of mechanical removal of endothelium, and an attenuation of relaxation caused by formononetin was observed.
In fact, a careful examination of the concentration-response curves of formononetin revealed that methylene blue (10 µM) caused a greater degree of reduction, compared to L-NAME, of formononetin-induced relaxation of endothelium-intact preparations (will be discussed below). Nonetheless, our results clearly demonstrate that formononetin caused a NO-/endothelium-/guanylate cyclase-dependent relaxation.
The possible involvement of other NOS isoform such as the inducible NOS (iNOS) was considered. However, our results illustrate that iNOS probably plays no role in the enhanced NO release upon the challenge of formononetin as there was no mRNA and protein expression of iNOS could be detected in our preparations in response to formononetin and acetylcholine challenge (data not shown). In addition, no significant change in NOS activity caused by formononetin was detected in the absence of [Ca 2+ ] o . Thus, our results suggest that the Ca 2+ -dependent NOS isoform (i.e. eNOS)
but not the Ca 2+ -independent isoform (i.e. iNOS) is responsible for formononetin-induced NO release from endothelial cells. In line with these observations, 1400W (a highly selective iNOS inhibitor) [29] failed to alter formononetin-induced endothelium-dependent relaxation. 21 In addition to the involvement of NO/eNOS cascade of endothelial cells, the relaxation response of formononetin reduced after the removal of the influence of NO/endothelium (although the magnitude of relaxation was smaller compared to that observed in endothelium-intact preparations) suggesting that formononetin caused an endothelium-independent relaxation. As mentioned above, methylene blue (a soluble guanylate cyclase inhibitor), glibenclamide (a K ATP channel inhibitor) and iberiotoxin µM, 1 mM) on phospho-eNOS Ser 1177 protein and total eNOS protein expression of rat isolated aorta (endothelium intact). Data are expressed as means ± S.E.M. (n = 5). *P < 0.05, **P < 0.01 and ***P < 0.001 versus control.
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